Stanford Cancer Institute earns highest cancer center designation
The STANFORD CANCER INSTITUTE has been designated a Comprehensive Cancer Center by the National Cancer Institute (NCI), a part of the National Institutes of Health and the world’s leading cancer research organization.
The designation recognizes the institute’s robust and integrated programs encompassing laboratory research, clinical care and community outreach and education.
The institute’s mission is to support and coordinate cancer-related activities — in basic, translational, clinical and population-based science — at Stanford, Stanford Health Care and Lucile Packard Children’s Hospital Stanford, along with its partner institution, the Cancer Prevention Institute of California. Its nearly 400 members include scientists and physicians collaborating to translate research advances into improved cancer treatments.
The institute achieved its initial NCI “cancer center” designation in 2007. In less than eight years, it has expanded its reach and its programs to earn the coveted “comprehensive” status.
“I want to recognize DR. BEVERLY MITCHELL, who has worked tirelessly since becoming the SCI director in 2008 to achieve this prestigious honor for Stanford Medicine,” said LLOYD MINOR, dean of the School of Medicine. “The combined effort of the institute’s multidisciplinary membership exemplifies how we are applying precision health to complex diseases and improving patient outcomes.”